Recent MSK Discoveries & Advances

Our Research Impact
Paul Marks Prize for Cancer Research
Recent MSK Discoveries & Advances
Research Awards & Honors
Researcher Interviews
Emeritus Faculty

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
375 News Items found
In the Lab
Confocal microscopic image of mouse lymphedema tissue with staining for immune cells and lymphatic vessels.
Researchers Zero In on the Cause of Lymphedema, a Debilitating Cancer Complication

Learn how an MSK laboratory is bringing much-needed focus to cancer-related lymphedema and investigating new ways to prevent the complication.
In the Clinic
Medical oncologist Nai-Kong Cheung
FDA Grants Breakthrough Therapy Designation to Naxitamab for Neuroblastoma

Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA.
Finding
Colored dots (cells) separating through a funnel-like structure.
Large Study Pinpoints Genetic Changes Underlying Drug Resistance in the Most Common Type of Breast Cancer

Scientists are learning how estrogen receptor-positive breast cancer evolves to thwart hormonal therapies and are developing ways to stop it.
In the Lab
Pancreatic tumor cells
Studying a Forerunner of Pancreatic Cancer Reveals New Clues about How the Disease Develops

This research is important for developing better drugs and screening methods for pancreatic tumors.
In the Lab
Sloan Kettering Institute molecular biologist Christine Mayr
Scientists Find Cancer Drivers Hiding in a New Place

New findings from researchers at the Sloan Kettering Institute suggest that cancer causes may be lurking in the molecule that bridges DNA and protein.
In the Lab
MSK Scientists Build "Armored" CAR T Cells to Smite Solid Tumors

The engineered immune cells secrete powerful drugs as a layer of defense.
Ask the Expert
Five people on the beach during a sunset
Does Vitamin D Reduce the Risk of Getting Cancer?

Two MSK medical oncologists discuss the link between the "sunshine vitamin" and cancer.
Announcement
Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello
FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia

The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.
In the Lab
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"

Targeting this signal with drugs might be one way to stop cancers from spreading.
Feature
MSK cell manufacturing specialist Xiuyan Wang
Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy

An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.